-DNA The Union government decision to decontrol prices of 108 drugs -- used to treat tuberculosis, AIDS, diabetes and heart ailments -- has jacked up their prices. In some cases, prices have seen an unbelievable rise. The price of Glivec, an anti-cancer tablet, for example, has risen from Rs 8,500 to Rs 1.08 lakh. Plavix, used to treat blood pressure and heart ailments, will cost Rs 1,615, against the earlier Rs 147. An...
More »SEARCH RESULT
New drug era -Shamnad Basheer
-The Indian Express Prime Minister Narendra Modi's US visit is likely to throw up highly contentious intellectual property rights issues. Indeed, for the last several years, US drug majors and their European counterparts have lobbied hard to demonise the Indian patent regime. But the government must continue to defend the law and stand its ground. Particularly since our own industrial moguls have caved in and are less vocal about their opposition...
More »Made in India, by small enterprises -Charan Singh
-The Hindu The Prime Minister's call for making India a manufacturing hub and creating jobs should boost small and medium enterprises as well Prime Minister Narendra Modi's ‘Make in India' campaign is creating waves both in India and abroad. Given the government's intention to boost domestic manufacturing and create new jobs, its proposal to introduce a new policy for Micro, Small and Medium Enterprises (MSMEs) deserves a closer look. While Mr. Modi's...
More »Government curbs power of regulator to cap HIV, cancer drug prices -Rupali Mukherjee
-The Times of India MUMBAI: In a move that will disappoint many patients, the government has withdrawn certain powers of the drug pricing regulator that allowed it to cap prices of widely prescribed anti-diabetes, cancer, HIV, tuberculosis and cardiac medicines. The National Pharmaceutical Pricing Authority (NPPA) said it is withdrawing "with immediate effect" - a guideline that had allowed it to put price caps on crucial medicines - to comply with a...
More »Health plan hits rough weather -Pranesh Sarkar
-The Telegraph Kolkata: The Bengal government's decision to select insurance companies quoting the lowest premiums for a centrally funded health care scheme has hit private hospitals that are refusing patients citing non-payment of claims by the firms. Senior officials of the health department said thousands of poor patients registered under the Rashtriya Swasthya Bima Yojana were being refused admission by hospitals and nursing homes across the state every month. The registered families...
More »